
Remepy (רמפי בריאות בע)
Remepy (רמפי בריאות בע)
Claim
We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its co Show MoreWe believe that in the future, software applications will become an integral part of treatments offe Show More
Alpha Score
$ 10.00 M
Alpha Score
59.3
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0